We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Novel therapeutics

Novel Purification Approaches To Streamline Manufacturing of Antibody-Based Therapeutics

The global market for antibody therapeutics is rising rapidly and newer, engineered modalities such as bi-specific antibodies and antibody fragments are entering clinical studies in record numbers.

Protein A chromatography is widely adopted for the purification of therapeutic monoclonal antibodies (mAbs). It offers an effective and efficient purification step in the mAb manufacturing process. However, with the development of novel modalities, downstream process scientists are looking into alternative solutions to expand their antibody purification toolbox. Affinity chromatography resins, specifically developed to bind antibody-subdomain regions, can provide an alternative solution in the purification process of these new formats. Thus, advancing the commercial production of new antibody therapeutics

Join us in this webinar to learn more on:

  • Addressing today’s challenges in antibody therapeutic workflows
  • How affinity chromatography could benefit your antibody polishing process
Keynote Speaker
Laurens Sierkstra
Laurens Sierkstra
Business Segment Leader, Bioproduction Group, Thermo Fisher Scientific ™
Brought to you by
Watch this Webinar for FREE Below
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar